Condition: Adults (Male and Female Subjects) With Tobacco Dependence · Sponsor: Assistance Publique - Hôpitaux de Paris
In summary, there are currently many therapeutic tools for achieving some degree of control or even cessation of tobacco addictive use. No single therapy seems to have proven itself sufficiently effective to be the preferred treatment axis in the management of this addiction. We can also point out that so far the main treatments aimed at reducing or controlling the craving phenomenon are of a pharmacological nature, thus exposing the participants to the side effects inherent to this type of treatment. In this perspective, the establishment of non invasive brain stimulation (TdCS), acting in a targeted manner on craving and whose effects would be mild and transient, appears quite justified, especially in addition to psychotherapy. In the context of the management of addictive pathologies, the choice of smoking dependence seems relevant to us insofar as this addiction represents a major public health problem.
This description comes directly from the study's public registry record.
Florence THIBAUT, PHD · (33) 1 58 41 16 79 · florence.thibaut@aphp.fr
Marie BENHAMMANI-GODARD · (33) 1 58 41 11 90 · marie.godard@aphp.fr
Always discuss trial participation with your own doctor first.
| Psychiatrie Adultes Et Addictologie | Paris, IDF, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04209153